Identification of a 6-gene signature predicting prognosis for colorectal cancer

Shuguang Zuo; Gongpeng Dai; Xuequn Ren

doi:10.1186/s12935-018-0724-7

Identification of a 6-gene signature predicting prognosis for colorectal cancer

Cancer Cell Int. 2019 Jan 5:19:6. doi: 10.1186/s12935-018-0724-7. eCollection 2019.

Authors

Shuguang Zuo^#^{1

2}, Gongpeng Dai^#³, Xuequn Ren³

Affiliations

¹ 1Center for Translational Medicine, Huaihe Hospital of Henan University, Kaifeng, 475001 Henan Province China.
² 2Institute of Infection and Immunity, Huaihe Hospital of Henan University, Kaifeng, 475001 Henan Province China.
³ 3Department of General Surgery, Huaihe Hospital of Henan University, Kaifeng, 475001 Henan Province China.

^# Contributed equally.

Abstract

Background: An accurate and robust gene signature is of the utmost importance in assisting oncologists to make a more accurate evaluation in clinical practice. In our study, we extracted key mRNAs significantly related to colorectal cancer (CRC) prognosis and we constructed an expression-based gene signature to predict CRC patients' survival.

Methods: mRNA expression profiles and clinicopathological data of colon adenocarcinoma (COAD) cases and rectum adenocarcinoma (READ) were collected from The Cancer Genome Atlas database to investigate gene expression alteration associated to the prognosis of CRC. Differentially expressed mRNAs (DEMs) were detected between COAD/READ and normal tissue samples. Relying on a univariate and multivariate Cox regression analyses, a mRNA panel signature was established and used for predicting the overall survival (OS) in CRC patients. Receiver operating characteristic curve was used to evaluate the prognosis performance of our model through calculating the AUC values corresponding to the 3-year and 5-year survival. To assess the performance of gene signature in the given cancer subgroups (CRC entire cohort, COAD cohort, and READ cohort), a stratified analysis was carried out according to clinical factors.

Results: A total of 5341 and 5594 DEMs were collected from COAD vs. normal tissue samples, and READ vs. normal samples respectively. A univariate regression analysis for the common DEMs between COAD and READ cohorts resulted in 14 common mRNAs related to OS. The multivariate Cox regression analysis revealed that 6 of these mRNAs (EPHA6, TIMP1, IRX6, ART5, HIST3H2BB, and FOXD1) had significant prognostic value allowing the discrimination between high- and low-risk patients, implying poor and good outcomes, respectively. The stratified analysis identified 6-gene signature as an independent prognostic signature in predicting CRC patients' survival.

Conclusions: The 6-gene signature could act as an independent biomarker for survival prediction of CRC patients.

Keywords: Colorectal cancer; Differentially expressed mRNA; Gene signature; High- and low-risk; Overall survival; Prognosis.